Increases in non-healthy behaviors such as drinking and less exercise has been attributed to the COVID-19 pandemic. The incidence was seen with the use of 18F-fluorocholine PET/CT and 68Ga-PSMA-11 PET/CT. The study is the first to show that lingering COVID-19 symptoms can be attributed to ongoing lung inflammation. JNCI Cancer Spectr. 2022 May 2;6(3):pkac035. doi: 10.1093/jncics/pkac035. ... This study offers a realist approach to rethinking and operationalizing the WHO 2017 guide to cancer early diagnosis. Front Oncol. 2022 May 12;12:872765. doi: 10.3389/fonc.2022.872765. eCollection 2022. ... Microorganisms. 2022 May 12;10(5):1021. doi: 10.3390/microorganisms10051021. ... Clin Nucl Med. 2022 May 27. doi: 10.1097/RLU.0000000000004288. Online ahead of print. ... Urol Case Rep. 2022 May 20:102121. doi: 10.1016/j.eucr.2022.102121. Online ahead of print. ... Biomed Res Int. 2022 May 19;2022:5739574. doi: 10.1155/2022/5739574. eCollection 2022. ... Commun Med (Lond). 2021 Aug 23;1:24. doi: 10.1038/s43856-021-00025-z. eCollection 2021. ... Researchers examined the association between the pandemic and prostate biopsy and cancer diagnosis. An overview of the effects of the COVID-19 pandemic on patient care and its effects on oncology care and medical education. The COVID-19 pandemic has brought about unprecedented changes in urologic care. A scientific session from the SNMMI Annual Meeting details how imaging can assess the impact of COVID-19 in cancer patients. The COVID-19 outbreak impacted patients with prostate cancer by causing a delay in the administration treatment. Patients with COVID-19 reported increased genitourinary symptoms. Previous Bacillus Calmette-Guérin therapy impacts COVID risk in bladder cancer. A study evaluated trends in outpatient prostate cancer throughout the COVID-19 pandemic using a community-based registry. Jeremy Warner summarizes the paper published in Lancet describing the outcome of cancer patients with COVID-19.